Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme.

Clicks: 381
ID: 72694
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 4 articles by views in biofactors (oxford, england)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Quercetin, a plant-derived flavonoid, is known for its antitumor and antiproliferative activities. Glioblastoma multiforme (GBM), as a highly aggressive cerebrum tumor, has a poor prognosis that is approximately 12 months despite standard therapy. Therefore, because of the low effectiveness of the current therapeutic strategies, additional medications in combination with chemotherapy and radiotherapy are needed, which could improve the prognosis of GBM patients. Multiple lines of evidence have shown that quercetin regulates many proteins involved in the cellular signal transduction in GBM. In this review, recent findings on the targeting of particular signaling pathways by quercetin and the subsequent effect on the pathogenesis of GBM are presented and discussed.
Reference Key
tavana2019quercetinbiofactors Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tavana, Erfan;Mollazadeh, Hamid;Mohtashami, Elmira;Modaresi, Seyed Mohamad Sadegh;Hosseini, Azar;Sabri, Hamed;Soltani, Arash;Javid, Hossein;Afshari, Amir R;Sahebkar, Amirhossein;
Journal biofactors (oxford, england)
Year 2019
DOI
10.1002/biof.1605
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.